@article{oai:repo.qst.go.jp:00049442,
 author = {Imaoka, Tatsuhiko and Nishimura, Mayumi and Daino, Kazuhiro and Takabatake, Masaru and Moriyama, Hitomi and Nishimura, Yukiko and Morioka, Takamitsu and Shimada, Yoshiya and Kakinuma, Shizuko and Imaoka, Tatsuhiko and Nishimura, Mayumi and Daino, Kazuhiro and Takabatake, Masaru and Moriyama, Hitomi and Nishimura, Yukiko and Morioka, Takamitsu and Shimada, Yoshiya and Kakinuma, Shizuko},
 issue = {10},
 journal = {International Journal of Radiation Biology},
 month = {Jan},
 note = {Purpose. To review recent studies to better understand the risk of second cancer after ion beam radiotherapy and to clarify the importance of animal radiobiology therein.
Results. Risk of developing second cancer after radiotherapy is a concern, particularly for survivors of childhood tumors. Ion beam radiotherapy is expected to reduce the risk of second cancer by reducing exposure of normal tissues to radiation. Large uncertainty lies, however, in the choice of relative biological effectiveness (RBE) of high linear energy transfer (LET) radiation (e.g., carbon ions and neutrons) in cancer induction, especially for children. Studies have attempted to predict the risk of second cancer after ion beam radiotherapy based on an assessment of radiation dose, the risk of low LET radiation, and assumptions about RBE. Animal experiments have yielded RBE values for selected tissues, radiation types, and age at the time of irradiation; the results indicate potentially variable RBE which depends on tissues, ages, and dose levels. Animal studies have also attempted to identify genetic alterations in tumors induced by high LET radiation. 
Conclusions. Estimating the RBE value for cancer induction is important for understanding the risk of second cancer after ion beam radiotherapy. More comprehensive animal radiobiology studies are needed.},
 pages = {1431--1440},
 title = {Risk of second cancer after ion beam radiotherapy: insights from animal carcinogenesis studies},
 volume = {95},
 year = {2019}
}